The spin-out company of Kyoto University which developed iPS-derived heart muscle cells based on the research results of Jun Yamashita of CiRA has obtained this funding mainly by Realtek which is run by Euglena capital, Kyowa Hakko Kirin, Japan Tobacco and others

Nikkei Biotech news release, May 17, 2016